-
1
-
-
84863115427
-
Plasma HIV-1 RNA detection below 50copies/mL and risk of virologic rebound in patients receiving highly active antiretroviral therapy
-
Doyle T., Smith C., Vitiello P., Cambiano V., Johnson M., Owen A., et al. Plasma HIV-1 RNA detection below 50copies/mL and risk of virologic rebound in patients receiving highly active antiretroviral therapy. Clin Infect Dis 2012, 54(5):724-732.
-
(2012)
Clin Infect Dis
, vol.54
, Issue.5
, pp. 724-732
-
-
Doyle, T.1
Smith, C.2
Vitiello, P.3
Cambiano, V.4
Johnson, M.5
Owen, A.6
-
2
-
-
56749149574
-
Determinants of virological failure after successful viral load suppression in first-line highly active antiretroviral therapy
-
Geretti A.M., Smith C., Haberl A., Garcia-Diaz A., Nebbia G., Johnson M., et al. Determinants of virological failure after successful viral load suppression in first-line highly active antiretroviral therapy. Antivir Ther 2008, 13(7):927-936.
-
(2008)
Antivir Ther
, vol.13
, Issue.7
, pp. 927-936
-
-
Geretti, A.M.1
Smith, C.2
Haberl, A.3
Garcia-Diaz, A.4
Nebbia, G.5
Johnson, M.6
-
3
-
-
34547478269
-
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study
-
Mocroft A., Phillips A.N., Gatell J., Ledergerber B., Fisher M., Clumeck N., et al. Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study. Lancet 2007, 370(9585):407-413.
-
(2007)
Lancet
, vol.370
, Issue.9585
, pp. 407-413
-
-
Mocroft, A.1
Phillips, A.N.2
Gatell, J.3
Ledergerber, B.4
Fisher, M.5
Clumeck, N.6
-
4
-
-
78650881529
-
HIV-1 load comparison using four commercial real-time assays
-
Bourlet T., Signori-Schmuck A., Roche L., Icard V., Saoudin H., Trabaud M.-A., et al. HIV-1 load comparison using four commercial real-time assays. J Clin Microbiol 2011, 49(1):292-297.
-
(2011)
J Clin Microbiol
, vol.49
, Issue.1
, pp. 292-297
-
-
Bourlet, T.1
Signori-Schmuck, A.2
Roche, L.3
Icard, V.4
Saoudin, H.5
Trabaud, M.-A.6
-
5
-
-
78149491596
-
Lack of correlation between three commercial platforms for the evaluation of human immunodeficiency virus type 1 (HIV-1) viral load at the clinically critical lower limit of quantification
-
Yan C.S., Hanafi I., Kelleher A.D., Carr A.D., Amin J., McNally L.P., et al. Lack of correlation between three commercial platforms for the evaluation of human immunodeficiency virus type 1 (HIV-1) viral load at the clinically critical lower limit of quantification. J Clin Virol 2010, 49(4):249-253.
-
(2010)
J Clin Virol
, vol.49
, Issue.4
, pp. 249-253
-
-
Yan, C.S.1
Hanafi, I.2
Kelleher, A.D.3
Carr, A.D.4
Amin, J.5
McNally, L.P.6
-
6
-
-
0004116672
-
-
Cambridge University Press, Cambridge
-
Finney D.J. Probit analysis 1971, Cambridge University Press, Cambridge. 3rd ed.
-
(1971)
Probit analysis
-
-
Finney, D.J.1
-
7
-
-
77950490354
-
Evaluation of an upgraded version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test for HIV-1 load quantification
-
Damond F., Avettand-Fenoel V., Collin G., Roquebert B., Plantier J.C., Ganon A., et al. Evaluation of an upgraded version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test for HIV-1 load quantification. J Clin Microbiol 2010, 48(4):1413-1416.
-
(2010)
J Clin Microbiol
, vol.48
, Issue.4
, pp. 1413-1416
-
-
Damond, F.1
Avettand-Fenoel, V.2
Collin, G.3
Roquebert, B.4
Plantier, J.C.5
Ganon, A.6
-
8
-
-
77955652621
-
Improved HIV-1 RNA quantitation by COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, v2.0 using a novel dual-target approach
-
Sizmann D., Glaubitz J., Simon C.O., Goedel S., Buergisser P., Drogan D., et al. Improved HIV-1 RNA quantitation by COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, v2.0 using a novel dual-target approach. J Clin Virol 2010, 49(1):41-46.
-
(2010)
J Clin Virol
, vol.49
, Issue.1
, pp. 41-46
-
-
Sizmann, D.1
Glaubitz, J.2
Simon, C.O.3
Goedel, S.4
Buergisser, P.5
Drogan, D.6
-
9
-
-
67249121143
-
Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy
-
Dinoso J.B., Kim S.Y., Wiegand A.M., Palmer S.E., Gange S.J., Cranmer L., et al. Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy. Proc Natl Acad Sci USA 2009, 106(23):9403-9408.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, Issue.23
, pp. 9403-9408
-
-
Dinoso, J.B.1
Kim, S.Y.2
Wiegand, A.M.3
Palmer, S.E.4
Gange, S.J.5
Cranmer, L.6
-
10
-
-
77749277080
-
Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy
-
McMahon D., Jones J., Wiegand A., Gange S.J., Kearney M., Palmer S., et al. Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy. Clin Infect Dis 2010, 50(6):912-919.
-
(2010)
Clin Infect Dis
, vol.50
, Issue.6
, pp. 912-919
-
-
McMahon, D.1
Jones, J.2
Wiegand, A.3
Gange, S.J.4
Kearney, M.5
Palmer, S.6
-
11
-
-
77949489461
-
Viral load assay sensitivity and low level viremia in HAART treated HIV patients
-
Verhofstede C., Van Wanzeele F., Reynaerts J., Mangelschots M., Plum J., Fransen K., et al. Viral load assay sensitivity and low level viremia in HAART treated HIV patients. J Clin Virol 2010, 47(4):335-339.
-
(2010)
J Clin Virol
, vol.47
, Issue.4
, pp. 335-339
-
-
Verhofstede, C.1
Van Wanzeele, F.2
Reynaerts, J.3
Mangelschots, M.4
Plum, J.5
Fransen, K.6
-
12
-
-
70449411747
-
HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy
-
Mavigner M., Delobel P., Cazabat M., Dubois M., L'Faqihi-Olive F.-E., Raymond S., et al. HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy. PLoS ONE 2009, 4(10):e7658.
-
(2009)
PLoS ONE
, vol.4
, Issue.10
-
-
Mavigner, M.1
Delobel, P.2
Cazabat, M.3
Dubois, M.4
L'Faqihi-Olive, F.-E.5
Raymond, S.6
-
13
-
-
84155162676
-
Low-level viraemia on HAART: significance and management
-
Doyle T., Geretti A.M. Low-level viraemia on HAART: significance and management. Curr Opin Infect Dis 2012, 25(1):17-25.
-
(2012)
Curr Opin Infect Dis
, vol.25
, Issue.1
, pp. 17-25
-
-
Doyle, T.1
Geretti, A.M.2
-
14
-
-
84873367194
-
Comparison of HIV-1 viral load assay performance in immunological stable patients with low or undetectable viremia
-
Naeth G., Ehret R., Wiesmann F., Braun P., Knechten H., Berger A., et al. Comparison of HIV-1 viral load assay performance in immunological stable patients with low or undetectable viremia. Med Microbiol Immunol 2012 Jun 15.
-
(2012)
Med Microbiol Immunol
-
-
Naeth, G.1
Ehret, R.2
Wiesmann, F.3
Braun, P.4
Knechten, H.5
Berger, A.6
|